Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Cardiovascular benefits have been demonstrated in clinical trials for specific GLP-1 receptor agonists, with liraglutide, semaglutide, and dulaglutide showing reductions in major adverse cardiovascular events in patients with established cardiovascular disease or high cardiovascular risk
Relative Precaution To make this clearer, our team put together a simple table to distinguish between a hard 'no' and a 'proceed with extreme caution' scenario
Warning Signs to Keep in Mind If youre sticking to your GLP-1 regimen but still not seeing progress, it might be time to check in with your doctor
Demographic and clinical data were collected, and symptoms were assessed using the Zung Self-Rating Depression Scale (SDS), Zung Self-Rating Anxiety Scale (SAS), 9-item Fatigue Severity Scale (FSS), Pittsburgh Sleep Quality Index (PSQI), and Stroke Stigma Scale (SSS) at baseline (T1), one month (T2), three months (T3), and six months (T4) post-stroke
